1325
post-template-default,single,single-post,postid-1325,single-format-standard,stockholm-core-1.0.8,ctct-stockholm,select-child-theme-ver-1.1,select-theme-ver-5.1.5,ajax_fade,page_not_loaded,menu-animation-underline,header_top_hide_on_mobile,wpb-js-composer js-comp-ver-6.0.2,vc_responsive

American biomedical innovation is leading the world: Why would we stifle that? | Opinion

 

From Delawareonline: President Joe Biden was spot on when he recently told Congress that continued investment in research and development is essential to our country’s global leadership and economic security.

Fortunately, the American bioscience sector is a shining exemplar of our nation’s unparalleled ability to nurture and produce engines of innovation that both benefit humankind and drive extraordinary economic opportunity at home through just that kind of sustained investment.

The dramatic impact of this biomedical renaissance couldn’t be clearer:  Vaccines and therapeutics developed and produced in record time and at an unprecedented scale are leading the world out of the deadly clutches of a catastrophic pandemic.

Yet, despite this historic success story, a proposal is being considered in Congress that would jeopardize this leadership by applying foreign pricing models to breakthrough medicines. Read more:https://www.delawareonline.com/story/opinion/contributors/2021/05/21/delaware-leads-american-biomedical-innovation/5166978001/